| | | | | |
FATE Fate Therapeutics, Inc. | $2.4400 | -7.92% | $317.04M | $1.01M | |
| $41.1400 | -1.53% | $316.96M | $15.57K | |
MLP Maui Land & Pineapple Co. | $15.5800 | -1.95% | $316.84M | $6.06K | |
NMRA Neumora Therapeutics, Inc. Common Stock | $1.5150 | -7.62% | $316.83M | $1.44M | |
GALT Galectin Therapeutics Inc. | $3.5800 | -2.45% | $316.66M | $299.37K | |
NREF NexPoint Real Estate Finance, Inc. | $17.2600 | -1.54% | $316.64M | $44.79K | |
POLE Andretti Acquisition Corp. II Class A Ordinary Shares | $10.8100 | -0.19% | $316.34M | $250.00 | |
| $3.1200 | -7.96% | $316.09M | $491.71K | |
EFR Eaton Vance Senior Floating-Rate Fund | $10.5200 | -1.31% | $315.90M | $126.88K | |
SMTI Sanara MedTech Inc. Common Stock | $34.2600 | -0.06% | $315.59M | $249.20K | |
TVA Texas Ventures Acquisition III Corp Class A Ordinary Share | $10.5400 | +0.00% | $315.30M | $60.07K | |
ALTO Alto Ingredients, Inc. Common Stock | $4.1700 | -0.48% | $314.92M | $1.14M | |
RNGT Range Capital Acquisition Corp II Class A Ordinary Shares | $10.1400 | +0.10% | $314.51M | $10.00 | |
AFB Alliance National Municipal Income Fund, Inc. | $11.0000 | +0.27% | $314.46M | $77.76K | |
SSP The E.W. Scripps Company | $3.2900 | -4.91% | $314.14M | $202.62K | |
